By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PAREXEL International 

Corporate Headquarters
195 West Street
Waltham  Massachusetts  02451  U.S.A.
Phone: 781-487-9900 Fax: 781-487-0525



At PAREXEL, the best minds in the industry are simplifying the journey from science to new treatments—and getting them into the hands of those who need them most. If you join us, you can be a part of that. Through innovative processes and technology, your journey with us will not only be challenging but truly rewarding. PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.

Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.

PAREXEL Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates approximately 75 locations in over 50 countries around the world, and has more than 15,000 employees. For more information about PAREXEL International, visit

Key Statistics

Ownership: Public

Web Site: PAREXEL International
Employees: 15,000 worldwide
Symbol: PRXL

Company News
PAREXEL International (PRXL) Expansion Will Create 130 New Pharma Jobs 7/27/2015 6:36:34 AM
PAREXEL International (PRXL) Launches Next Generation Analytics Capabilities Within Perceptive MyTrials Platform 7/21/2015 11:07:34 AM
PAREXEL International (PRXL) Expands Model-Based Drug Development Offering 7/9/2015 9:41:34 AM
PAREXEL International (PRXL) Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 7/7/2015 7:34:48 AM
PAREXEL International (PRXL) to Cut 850 Jobs As New Guidance, Pfizer (PFE) Flow Force Restructuring 6/25/2015 7:05:46 AM
PAREXEL International (PRXL) Issues Earnings Guidance In Conjunction With Investor Day 6/24/2015 11:32:33 AM
PAREXEL International (PRXL) Launches Next Generation Data-Driven Monitoring Capabilities Within Perceptive MyTrials Solution 6/18/2015 7:21:08 AM
PAREXEL International (PRXL) Invites Public To Listen To Live Webcast Of Its Investor Day June 24, 2015 6/17/2015 9:23:41 AM
PAREXEL International (PRXL) Experts To Discuss Key Drug Development Insights At DIA 2015 Annual Meeting 6/8/2015 10:09:11 AM
PAREXEL International (PRXL) Enhances ClinPhone RTSM Service To Simplify And Expedite Randomization And Trial Supply Management For Clinical Studies 5/27/2015 8:09:56 AM